Richard N. Kolesnick: Overview

Figure 1

Figure 1 — Ceramide-rich platforms signal endothelial cell apoptosis, coordinating tumor cure for sterotactic radiosurgery

Our program uses a multidisciplinary approach involving genetics, biochemistry, and cell biology to address these issues. Knockouts of relevant genes are generated in mice and concomitantly in the nematode Caenorhabditis elegans. Studies in C. elegans provide information regarding the molecular ordering of ceramide signaling during stress and development, whereas studies in mice provide information of tissue/organ distribution of ceramide effects. The goal of these studies is to determine under what conditions the ceramide signal is involved in normal physiology and in pathophysiology of disease and the development of pharmacologic agents to suppress or enhance signaling through this system in vivo. Evidence suggests that the sphingomyelin pathway is critical for ionizing radiation-induced death of oocytes and endothelium, is co-opted by a variety of microorganisms as a mechanism to gain access to the cellular interior, and serves as an important co-signal for TNF receptor superfamily-induced death. Pre-clinical data suggest that the therapeutic success of stereotactic radiosurgery, a new form of high dose radiotherapy capable of curing radioresistant cancer, depends on ceramide-mediated apoptosis of the tumor microvascular network (see Figure 1).